Amicus Therapeutics competitorsClear all
Amicus Therapeutics's top competitors include Modis Therapeutics, Sanofi Genzyme, PhaseBio Pharmaceuticals and Paion.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. |  PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. |  Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. | ||
Founding Date | Founding Date 2002 | Founding Date 2016 | Founding Date 1981 | Founding Date 2002 | Founding Date 2000 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Oakland, US HQ | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Malvern, US HQ | Locations Aachen, DE HQ Mönchengladbach, DE Cambridge, GB |
Employees | Employees 58415% increase | Employees 109% decrease | Employees 9,9041% decrease | Employees 22 | Employees 3218% decrease |
Valuation ($) | Valuation ($) 3.1 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 32.7 m | Valuation ($) 60.2 m |
Twitter followers | Twitter followers 2 k | Twitter followers N/A | Twitter followers 59.6 k | Twitter followers 298 | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 10 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 4.4 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 4.5 | Average likes per tweet (last 30 days) 1.3 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 66.67% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 256484 | Alexa Website Rank N/A | Alexa Website Rank N/A | Alexa Website Rank 637541 | Alexa Website Rank 529818 |
Employee Rating | Employee Rating 2.9 | Employee Rating N/A | Employee Rating N/A | Employee Rating 5 | Employee Rating 3 |
Financial | |||||
Revenue (est.) | Revenue (est.) $260.9m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) $320k (FY, 2020) | Revenue (est.) €7.1m (FY, 2021) |
Cost of goods | Cost of goods $31m (FY, 2020) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods (€1.5m) (FY, 2021) |
Gross profit | Gross profit $229.8m (FY, 2020) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit €5.6m (FY, 2021) |
Net income | Net income ($276.9m) (FY, 2020) | Net income N/A | Net income N/A | Net income ($98.6m) (FY, 2020) | Net income (€21.8m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 88m | Total funding raised $ 30m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 15.2m |
For sources of this data, please see the company profile
View company profiles
Modis Therapeutics
HQ
Oakland, US
Modis Therapeutics develops treatments for rare genetic diseases.
View companySanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View companyPhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View companyPaion
HQ
Aachen, DE
Employees
32↓ 18% decrease
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
View company